Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study.,Journal of Clinical Psychopharmacology

当前位置： X-MOL 学术 › J. Clinical Psychopharmacol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Antipsychotic Polypharmacy Is Associated With Adverse Drug Events in Psychiatric Inpatients: The Japan Adverse Drug Events Study.
Journal of Clinical Psychopharmacology ( IF 2.9 ) Pub Date : 2021-06-08 , DOI: 10.1097/jcp.0000000000001416
Nobutaka Ayani , Takeshi Morimoto ₁ , Mio Sakuma ₁ , Toshiaki Kikuchi ₂ , Koichiro Watanabe ₃ , Jin Narumoto ₄

Affiliation

Antipsychotic (AP) polypharmacy (APP), the coprescription of more than 1 AP, is frequently practiced in psychiatric inpatients and is considered to be a risk factor for adverse drug events (ADEs). However, the association between APP and ADEs among psychiatric inpatients has not been well investigated.

中文翻译：

抗精神病药物多药与精神病住院患者的药物不良事件相关：日本药物不良事件研究。

抗精神病药 (AP) 多药 (APP) 是 1 种以上 AP 的共同处方，经常在精神病住院患者中使用，被认为是药物不良事件 (ADE) 的危险因素。然而，尚未对精神病住院患者中 APP 和 ADE 之间的关联进行深入研究。

更新日期：2021-06-16

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11